CELCORE ApS: Financial statements 2025
CVR: 44749432
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CELCORE ApS (CVR 44749432) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,163,813 and a net result of DKK -4,501,336. Equity in the 2025 report amounted to DKK -650,217. The company had 3 employees in the financial year.
- Gross Profit
- DKK -1,163,813
- Profit/Loss
- DKK -4,501,336
- Equity
- DKK -650,217
- Total Assets
- DKK 2,566,294
- Employees
- 3
How creditworthy is CELCORE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CELCORE ApS has published its interim report for the period April 8, 2024 – December 31, 2024.
About CELCORE ApS
CELCORE ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Stemmedical Group ApS and New Special Purpose Entity ApS. The management consists of Peter Bo Selvig. The company's owners include Christian Trojahn Riis-Madsen, D.B. AF 8/1 1996 ApS and MONTEREY INVEST ApS. In 2025, the company reported a gross profit of DKK -1,163,813 and a net result of DKK -4,501,336. Equity in the 2025 report amounted to DKK -650,217.